• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综合多组学分析确定PTPRG和CHL1为透明细胞肾细胞癌(ccRCC)免疫表型的关键调节因子。

Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC).

作者信息

Zeng Xing, Li Le, Hu Zhiquan, Peng Dan

机构信息

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Oncol. 2022 Mar 30;12:832027. doi: 10.3389/fonc.2022.832027. eCollection 2022.

DOI:10.3389/fonc.2022.832027
PMID:35433461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9005830/
Abstract

Despite the increasing importance and status of immune checkpoint blockade (ICB), little is known about the underlying molecular mechanisms determining the target clear cell renal cell carcinoma (ccRCC) population. In this study, we screened out 6 immune cells strongly correlated with expression levels of PD-L1 and IFN-γ based on the ccRCC samples extracted from GSE and TCGA data sets. By performing unsupervised clustering and lasso regression analysis, we grouped the ccRCC into 4 clusters and selected the two most distinct sub-clusters for further investigation-cluster A1 and B1. Next, we compared the two clusters in terms of mRNA, somatic mutations, copy number variations, DNA methylation, miRNA, lncRNA and constructed the differentially expressed genes (DEGs) hub by combing together the previous results at levels of DNA methylation, miRNA, and lncRNA. PTPRG and CHL1 were identified as key nodes in the regulation hub of immunophenotypes in ccRCC patients. Finally, we established the prognosis model by using Lasso-Cox regression and Kaplan-Meier analysis, recognizing WNT2, C17orf66, and PAEP as independent significant risk factors while IRF4 as an independent protective factor.

摘要

尽管免疫检查点阻断(ICB)的重要性和地位日益提高,但对于决定目标透明细胞肾细胞癌(ccRCC)群体的潜在分子机制却知之甚少。在本研究中,我们基于从GSE和TCGA数据集中提取的ccRCC样本,筛选出与PD-L1和IFN-γ表达水平密切相关的6种免疫细胞。通过进行无监督聚类和套索回归分析,我们将ccRCC分为4个簇,并选择两个最不同的子簇进行进一步研究——簇A1和B1。接下来,我们在mRNA、体细胞突变、拷贝数变异、DNA甲基化、miRNA、lncRNA方面比较了这两个簇,并通过整合先前在DNA甲基化、miRNA和lncRNA水平上的结果构建了差异表达基因(DEG)枢纽。PTPRG和CHL1被确定为ccRCC患者免疫表型调控枢纽中的关键节点。最后,我们通过套索-考克斯回归和卡普兰-迈耶分析建立了预后模型,确定WNT2、C17orf66和PAEP为独立的显著危险因素,而IRF4为独立的保护因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/e395c5ce3410/fonc-12-832027-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/bb4d2640dbe8/fonc-12-832027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/556faf5425cf/fonc-12-832027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/75520934a41c/fonc-12-832027-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/404b69f24bdc/fonc-12-832027-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/672fead63762/fonc-12-832027-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/5829bac3381e/fonc-12-832027-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/02464e46d78e/fonc-12-832027-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/376aab2c25aa/fonc-12-832027-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/71c0c516a9bc/fonc-12-832027-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/c8526f466ff6/fonc-12-832027-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/a9fed2d28bcf/fonc-12-832027-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/79c3988169e3/fonc-12-832027-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/87fcef722a2d/fonc-12-832027-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/2190ed447e2d/fonc-12-832027-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/e395c5ce3410/fonc-12-832027-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/bb4d2640dbe8/fonc-12-832027-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/556faf5425cf/fonc-12-832027-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/75520934a41c/fonc-12-832027-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/404b69f24bdc/fonc-12-832027-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/672fead63762/fonc-12-832027-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/5829bac3381e/fonc-12-832027-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/02464e46d78e/fonc-12-832027-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/376aab2c25aa/fonc-12-832027-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/71c0c516a9bc/fonc-12-832027-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/c8526f466ff6/fonc-12-832027-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/a9fed2d28bcf/fonc-12-832027-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/79c3988169e3/fonc-12-832027-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/87fcef722a2d/fonc-12-832027-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/2190ed447e2d/fonc-12-832027-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e2/9005830/e395c5ce3410/fonc-12-832027-g015.jpg

相似文献

1
Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC).综合多组学分析确定PTPRG和CHL1为透明细胞肾细胞癌(ccRCC)免疫表型的关键调节因子。
Front Oncol. 2022 Mar 30;12:832027. doi: 10.3389/fonc.2022.832027. eCollection 2022.
2
Discovery and construction of prognostic model for clear cell renal cell carcinoma based on single-cell and bulk transcriptome analysis.基于单细胞和批量转录组分析的透明细胞肾细胞癌预后模型的发现与构建
Transl Androl Urol. 2021 Sep;10(9):3540-3554. doi: 10.21037/tau-21-581.
3
Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.与肿瘤免疫浸润相关的铁死亡相关长链非编码RNA特征分析及在肾透明细胞癌中的实验验证
Int J Gen Med. 2022 Mar 19;15:3215-3235. doi: 10.2147/IJGM.S354682. eCollection 2022.
4
A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.一种基于新型免疫相关长链非编码RNA的透明细胞肾细胞癌生存预测模型。
J Immunol Res. 2021 Jun 28;2021:9921466. doi: 10.1155/2021/9921466. eCollection 2021.
5
Comprehensive Analysis of mC RNA Methylation Regulator Genes in Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌中m⁶A RNA甲基化调节基因的综合分析
Int J Genomics. 2021 Sep 28;2021:3803724. doi: 10.1155/2021/3803724. eCollection 2021.
6
N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.N6-甲基腺苷 RNA 甲基化调控因子参与肾透明细胞癌的恶性进展,并具有预后价值。
Oncol Rep. 2020 May;43(5):1591-1605. doi: 10.3892/or.2020.7524. Epub 2020 Feb 28.
7
Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.生物信息学分析和验证肾透明细胞癌的基因靶点。
Comput Biol Chem. 2021 Jun;92:107453. doi: 10.1016/j.compbiolchem.2021.107453. Epub 2021 Feb 9.
8
Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.透明细胞肾细胞癌患者中竞争性内源性RNA网络的构建及与远处转移和不良预后相关的3个关键长链非编码RNA特征的验证
Front Oncol. 2021 Mar 24;11:640150. doi: 10.3389/fonc.2021.640150. eCollection 2021.
9
Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.通过生物信息学分析对透明细胞肾细胞癌中新型关键基因ITGAX、LAPTM5、SERPINE1进行预测与分析
PeerJ. 2021 Apr 20;9:e11272. doi: 10.7717/peerj.11272. eCollection 2021.
10
Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.一种用于预测透明细胞肾细胞癌预后及辅助免疫治疗的甲基化调控基因预后特征的鉴定
Front Cell Dev Biol. 2022 Mar 2;10:832803. doi: 10.3389/fcell.2022.832803. eCollection 2022.

引用本文的文献

1
The multiple roles of interferon regulatory factor family in health and disease.干扰素调节因子家族在健康和疾病中的多重作用。
Signal Transduct Target Ther. 2024 Oct 9;9(1):282. doi: 10.1038/s41392-024-01980-4.
2
Comprehensive Analysis of Angiogenesis and Ferroptosis Genes for Predicting the Survival Outcome and Immunotherapy Response of Hepatocellular Carcinoma.用于预测肝细胞癌生存结果和免疫治疗反应的血管生成与铁死亡基因的综合分析
J Hepatocell Carcinoma. 2024 Sep 29;11:1845-1859. doi: 10.2147/JHC.S483647. eCollection 2024.
3
Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics.

本文引用的文献

1
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis.免疫检查点抑制剂治疗临床试验中泌尿系统癌症患者的不良反应:协作性系统评价和荟萃分析。
Eur Urol. 2022 Apr;81(4):414-425. doi: 10.1016/j.eururo.2022.01.028. Epub 2022 Jan 31.
2
The Role of the Tumor Suppressor Gene Protein Tyrosine Phosphatase Gamma in Cancer.肿瘤抑制基因蛋白酪氨酸磷酸酶γ在癌症中的作用
Front Cell Dev Biol. 2022 Jan 5;9:768969. doi: 10.3389/fcell.2021.768969. eCollection 2021.
3
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
代谢分类的肾细胞癌揭示了与临床和免疫特征的内在联系。
J Transl Med. 2023 Feb 24;21(1):146. doi: 10.1186/s12967-023-03978-y.
4
A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis.血清中的一个包含四种微小RNA的组合可能作为肾细胞癌诊断的潜在生物标志物。
Front Oncol. 2023 Jan 16;12:1076303. doi: 10.3389/fonc.2022.1076303. eCollection 2022.
5
Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes.基于脂肪酸代谢相关基因的肾透明细胞癌新特征的预后与疼痛剖析
Front Oncol. 2022 Dec 9;12:1094657. doi: 10.3389/fonc.2022.1094657. eCollection 2022.
6
Oxidative Phosphorylation-Related Signature Participates in Cancer Development, and PTPRG Overexpression Suppresses the Cancer Progression in Clear Cell Renal Cell Carcinoma.氧化磷酸化相关特征参与癌症发生,PTPRG 过表达抑制透明细胞肾细胞癌的癌症进展。
J Immunol Res. 2022 Nov 10;2022:8300187. doi: 10.1155/2022/8300187. eCollection 2022.
7
A Potential Fatty Acid Metabolism-Related Gene Signature for Prognosis in Clear Cell Renal Cell Carcinoma.一种用于预测透明细胞肾细胞癌预后的潜在脂肪酸代谢相关基因特征。
Cancers (Basel). 2022 Oct 9;14(19):4943. doi: 10.3390/cancers14194943.
8
Prognostic Role of M6A-Associated Immune Genes and Cluster-Related Tumor Microenvironment Analysis: A Multi-Omics Practice in Stomach Adenocarcinoma.m6A相关免疫基因的预后作用及与簇相关的肿瘤微环境分析:胃癌的多组学实践
Front Cell Dev Biol. 2022 Jun 24;10:935135. doi: 10.3389/fcell.2022.935135. eCollection 2022.
仑伐替尼联合帕博利珠单抗或依维莫司治疗晚期肾细胞癌。
N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Reconstruction of Immune Microenvironment and Signaling Pathways in Endometrioid Endometrial Adenocarcinoma During Formation of Lymphovascular Space Involvement and Lymph Node Metastasis.子宫内膜样腺癌淋巴管间隙侵犯和淋巴结转移形成过程中免疫微环境及信号通路的重建
Front Oncol. 2020 Dec 9;10:595082. doi: 10.3389/fonc.2020.595082. eCollection 2020.
6
MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma.抑制巨噬细胞移动抑制因子作为克服黑色素瘤对免疫检查点阻断疗法耐药性的一种策略。
Oncoimmunology. 2020 Dec 6;9(1):1846915. doi: 10.1080/2162402X.2020.1846915.
7
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial.派姆单抗联合阿昔替尼对比舒尼替尼作为晚期肾细胞癌的一线治疗(KEYNOTE-426):一项随机、开放标签、III 期试验的延长随访。
Lancet Oncol. 2020 Dec;21(12):1563-1573. doi: 10.1016/S1470-2045(20)30436-8. Epub 2020 Oct 23.
8
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.透明细胞肾细胞癌的发生机制及致死机制。
Nat Rev Nephrol. 2021 Apr;17(4):245-261. doi: 10.1038/s41581-020-00359-2. Epub 2020 Nov 3.
9
Targeting the epigenetic regulation of antitumour immunity.靶向抗肿瘤免疫的表观遗传调控。
Nat Rev Drug Discov. 2020 Nov;19(11):776-800. doi: 10.1038/s41573-020-0077-5. Epub 2020 Sep 14.
10
Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis.免疫细胞浸润分析和生物信息学鉴定乳头状肾细胞癌微环境中的预后价值基因。
Biomed Res Int. 2020 Jul 25;2020:5019746. doi: 10.1155/2020/5019746. eCollection 2020.